Skip to content

Clinical trials

Phase 2 Multiple Myeloma trials in Norway

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Multiple Myeloma Phase: Phase 2 Country / region: Norway Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20051
20071
20091
20141
20151
20161
20181
20212
20241
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Active, not recruiting2
Recruiting2
Unknown status2
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
European Myeloma Network B.V.1
European Society for Blood and Marrow Transplantation1
Henrik Gregersen1
Ida Bruun Kristensen1
Nordic Myeloma Study Group1
North Estonia Medical Centre1
Novartis Pharmaceuticals1
Odense University Hospital1
Oslo University Hospital1
Raija Silvennoinen1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Multiple Myeloma13
Recurrence3
Neoplasms2
Biliary Tract Neoplasms1
Gastrointestinal Stromal Tumors1
Glioma1
Leukemia, Hairy Cell1
Neoplasms, Plasma Cell1
Thyroid Carcinoma, Anaplastic1

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.